Trial
NCT01176565
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
University of Minnesota
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS); Medical University of South Carolina; Johns Hopkins University; University of Michigan; Neurocritical Care Research Network; National Cerebral and Cardiovascular Center, Japan; Japan Cardiovascular Research Foundation; Beijing Tiantan Hospital; China Medical University Hospital; University Hospital Heidelberg; Seoul National University Hospital
Condition
Intracerebral Hemorrhage
Intervention
Intravenous nicardipine hydrochloride
Why stopped
Planned interim analysis: no significant outcome differences between groups
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-25